Successful Use of Tralokinumab in a Pediatric Patient With <scp>STAT3</scp> Hyper‐ <scp>IgE</scp> Syndrome Following Dupilumab‐Associated Conjunctivitis
The authors declare no conflicts of interest. The data that support the findings of this study are openly available in Mendeley Data at: https://doi.org/10.17632/m86nv2w5nx.1.
Authors
- E. de Eusebio‐Murillo
- Aranzazú Vergara‐Sanchez
- Jose María Camino‐Salvador (ORCID: https://orcid.org/0000-0002-3818-1615)
- Javier Torres‐Marcos
- Isabel Zapata‐Martínez
- Eva Castillo‐Castillo
Institutions
- Hospital Universitario de Guadalajara (ES)
Publication Details
- Journal
- International Journal of Dermatology
- Published
- 2025-11-12
- DOI
- https://doi.org/10.1111/ijd.70147
- Primary Topic
- Immunodeficiency and Autoimmune Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00